What can trigger the need for reconsent during a study?

Short answer

Reconsent may be needed when new information could materially change a participant’s decision to continue, such as a newly identified risk, an important change to study procedures or new treatment alternatives. The sponsor and investigators should follow the applicable ethics and regulatory review process.

Why

Informed consent is an ongoing conversation rather than a one-time signature. During a study, investigators may learn about a serious adverse reaction, change the intervention, lengthen follow-up or discover information that affects reasonable expectations of benefit. They must consider whether participants need updated information promptly and whether a revised information sheet, new consent discussion or documented reconsent is required.

Protocol amendments and revised consent forms generally involve ethics committee or IRB processes as applicable, with exceptions for urgent safety measures handled under the rules of the jurisdiction. Reconsent does not mean that every administrative document revision requires all participants to sign again. The test is whether the new information matters to voluntary, informed participation and how the authorized process instructs the site to communicate it.

An example

A new safety signal materially increases the risk of a trial drug. Current participants receive updated information, time to ask questions and any required documented consent before affected procedures continue.

Common mistakes

Treating consent as a form completed once, or automatically demanding reconsent for trivial wording changes

The interviewer might ask next

How would you handle a participant who wants to withdraw after receiving new risk information?